Guidance
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness
Authors
Languages
- Spanish
Publication year
2021
Type
Guidance
Categories
- Programme management
Diseases
- COVID-19
- SARS
Tags
- Planning, budgeting and financing
